Advertisement
Screener

Cumberland Pharmaceuticals Inc. (CPIX) Net Cash Provided by (Used in) Investing Activities, Continuing Operations

1.9 / 5 stars · 28/75 Roast Me

Cumberland Pharmaceuticals Inc. Net Cash Provided by (Used in) Investing Activities, Continuing Operations

Cumberland Pharmaceuticals Inc. (CPIX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$1.84 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2026-08-07

  • 2026-06-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month -$1.84M.
  • 2025-06-30: Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month -$84.64K.
Period endNet Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month
2026-06-30-$1.84M
10-Q · filed 2026-08-07
2025-06-30-$84.64K
10-Q · filed 2026-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31